FIRAZYR: payments to doctors
Payments that named FIRAZYR as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $17K
- Providers
- 29
- Transactions
- 35
- Average per transaction
- $498
The per-transaction average — $498 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 29 providers the average total is $601, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $16,817 | 96.5% |
| Shire North American Group Inc | $616 | 3.5% |